Marie Shella De Robles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marie Shella De Robles has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Christopher John Young
The University of Sydney, Faculty of Medicine and Health Sydney Medical School Sydney New South Wales Australia
7 shared publications - Ali Phillip Mourad
Department of Surgery, The Wollongong Hospital, Wollongong, NSW 2500, Australia
4 shared publications Robert Winn
Department of Surgery Wollongong Hospital Wollongong Australia
3 shared publications- Andrew Still
Department of Colorectal Surgery The Wollongong Hospital Sydney New South Wales Australia
2 shared publications Christopher J. Young
Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; The University of Sydney, Discipline of Surgery, Sydney, New South Wales, Australia
2 shared publications- Ji Chen
Westmead Clinical School, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia
2 shared publications
Latest Publications
- Open Access
- 3 February 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (2) , rjaf034
Spontaneous transomental hernia: a rare cause of closed loop bowel obstruction
Transomental hernias are the rarest subtype of internal hernias, accounting for 0.5%–3% of bowel obstructions. We report an unusual case of a spontaneous transomental hernia in a 47-year-old male presenting with non-specific obstructive symptoms. A CT scan revealed a closed-loop small bowel obstruction, but the diagnosis of a spontaneous transomental hernia was confirmed during emergency diagnostic laparoscopy. The small bowel remained viable, avoiding the need for resection, and the patient had an uncomplicated postoperative recovery. Clinical suspicion for transomental hernias is crucial, especially in patients with no prior abdominal surgery, to ensure early surgical intervention and reduced morbidity.
- 3 February 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (2) , rjaf034
Open AccessSpontaneous transomental hernia: a rare cause of closed loop bowel obstruction
Transomental hernias are the rarest subtype of internal hernias, accounting for 0.5%–3% of bowel obstructions. We report an unusual case of a spontaneous transomental hernia in a 47-year-old male presenting with non-specific obstructive symptoms. A CT scan revealed a closed-loop small bowel obstruction, but the diagnosis of a spontaneous transomental hernia was confirmed during emergency diagnostic laparoscopy. The small bowel remained viable, avoiding the need for resection, and the patient had an uncomplicated postoperative recovery. Clinical suspicion for transomental hernias is crucial, especially in patients with no prior abdominal surgery, to ensure early surgical intervention and reduced morbidity.
- Open Access
- 4 August 2023
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2023 (8) , rjad465
Double trouble: concomitant Meckel’s diverticulitis and acute appendicitis
Although Meckel’s diverticulum is the most common congenital anomaly of the small bowel (2% prevalence worldwide), it rarely causes symptoms, with only 4% of those with the anomaly developing any complications, including Meckel’s diverticulitis. In contrast to this, appendicitis is the most common general surgical emergency, with a lifetime incidence of 6.7–8.6%. Therefore, the case of a man presenting with right-sided abdominal pain to an Emergency Department with both Meckel’s diverticulitis and appendicitis is rare. This case study illustrates the importance of careful assessment of the entire abdomen when operating on patients with right-sided abdominal pain, so as not to miss Meckel’s diverticulitis even when appendicitis has already been found.
- 4 August 2023
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2023 (8) , rjad465
Open AccessDouble trouble: concomitant Meckel’s diverticulitis and acute appendicitis
Although Meckel’s diverticulum is the most common congenital anomaly of the small bowel (2% prevalence worldwide), it rarely causes symptoms, with only 4% of those with the anomaly developing any complications, including Meckel’s diverticulitis. In contrast to this, appendicitis is the most common general surgical emergency, with a lifetime incidence of 6.7–8.6%. Therefore, the case of a man presenting with right-sided abdominal pain to an Emergency Department with both Meckel’s diverticulitis and appendicitis is rare. This case study illustrates the importance of careful assessment of the entire abdomen when operating on patients with right-sided abdominal pain, so as not to miss Meckel’s diverticulitis even when appendicitis has already been found.
- 22 November 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (5) , 1367-1368
Pancreaticoduodenal artery aneurysm associated with coeliac stenosis: a potential bomb that carries no warning
- 22 November 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (5) , 1367-1368
Pancreaticoduodenal artery aneurysm associated with coeliac stenosis: a potential bomb that carries no warning
- Open Access
- 12 October 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (4) , 1040-1041
Pneumoretroperitoneum – is it always an ominous sign?
- 12 October 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (4) , 1040-1041
Open AccessPneumoretroperitoneum – is it always an ominous sign?
- Open Access
- 1 January 2022
- Published by Elsevier in Asian Journal of Surgery
- Vol. 45 (1) , 184-188
Real world outcomes of lateral internal sphincterotomy vs botulinum toxin for the management of chronic anal fissures
- 1 January 2022
- Published by Elsevier in Asian Journal of Surgery
- Vol. 45 (1) , 184-188
Open AccessReal world outcomes of lateral internal sphincterotomy vs botulinum toxin for the management of chronic anal fissures
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , S63
Real World Outcomes of Lateral Internal Sphincterotomy vs Botulinum Toxin for the Management of Chronic Anal Fissures
Lateral internal sphincterotomy (LIS) remains the gold standard surgical approach for the management of chronic anal fissures (CAF). The procedure, however, is complicated by the risk of postoperative incontinence. In recent years, intrasphincteric botulinum toxin (BT) has gained popularity as an alternative approach, despite being inferior to LIS with regard to cure rates. In the real world, patients at high risk for postoperative incontinence are likely to be offered BT as a preliminary procedure. The aim of this study was to explore the real-world outcomes of LIS and BT for a cohort of CAF patients.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , S63
Real World Outcomes of Lateral Internal Sphincterotomy vs Botulinum Toxin for the Management of Chronic Anal Fissures
Lateral internal sphincterotomy (LIS) remains the gold standard surgical approach for the management of chronic anal fissures (CAF). The procedure, however, is complicated by the risk of postoperative incontinence. In recent years, intrasphincteric botulinum toxin (BT) has gained popularity as an alternative approach, despite being inferior to LIS with regard to cure rates. In the real world, patients at high risk for postoperative incontinence are likely to be offered BT as a preliminary procedure. The aim of this study was to explore the real-world outcomes of LIS and BT for a cohort of CAF patients.
- Open Access
- 19 October 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 38 (5) , 376-379
Transperineal rectocele repair is ideal for patients presenting with fecal incontinence
Purpose: Rectocele can be associated with both obstructed defecation and fecal incontinence. There exists a great variety of operative techniques to treat patients with rectocele. The purpose of this study was to evaluate the clinical outcome in a consecutive series of patients who underwent transperineal repair of rectocele when presenting with fecal incontinence as the predominant symptom.Methods: Twenty-three consecutive patients from April 2000 to July 2015 with symptomatic rectocele underwent transperineal repair by a single surgeon.Results: All patients had a history of vaginal delivery, with or without evidence of associated anal sphincter injury at the time. The median age of the cohort was 53 years (range, 21–90 years). None were fully continent preoperatively. However, continence improved to just rare mucus soiling or loss of flatus in all patients 6 months after their surgery. There was no operative mortality. Postoperative complications including urinary retention and wound dehiscence occurred in 3 patients.Conclusion: Fecal incontinence associated with rectocele is multifactorial and may be caused by preexisting anal sphincteric damage and attenuation. Our experience suggests that transperineal repair provides excellent anatomic and physiologic results with minimal morbidity in selected patients presenting with combined rectocele and anal sphincter defect.
- 19 October 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 38 (5) , 376-379
Open AccessTransperineal rectocele repair is ideal for patients presenting with fecal incontinence
Purpose: Rectocele can be associated with both obstructed defecation and fecal incontinence. There exists a great variety of operative techniques to treat patients with rectocele. The purpose of this study was to evaluate the clinical outcome in a consecutive series of patients who underwent transperineal repair of rectocele when presenting with fecal incontinence as the predominant symptom.Methods: Twenty-three consecutive patients from April 2000 to July 2015 with symptomatic rectocele underwent transperineal repair by a single surgeon.Results: All patients had a history of vaginal delivery, with or without evidence of associated anal sphincter injury at the time. The median age of the cohort was 53 years (range, 21–90 years). None were fully continent preoperatively. However, continence improved to just rare mucus soiling or loss of flatus in all patients 6 months after their surgery. There was no operative mortality. Postoperative complications including urinary retention and wound dehiscence occurred in 3 patients.Conclusion: Fecal incontinence associated with rectocele is multifactorial and may be caused by preexisting anal sphincteric damage and attenuation. Our experience suggests that transperineal repair provides excellent anatomic and physiologic results with minimal morbidity in selected patients presenting with combined rectocele and anal sphincter defect.
- 6 April 2021
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (9) , 1866-1873
Survival in stage IIB/C compared to stage IIIA rectal cancer: an Australian experience affirming that size does matter
Background: Colorectal cancer (CRC) is one of the most commonly diagnosed malignancies globally; however, a survival paradox has been observed unique to this malignancy. The aim of this study was to review survival outcomes of patients diagnosed with stage II and stage III rectal cancer, to determine whether a survival paradox is present in our centre and assess for patient‐related factors that can explain the observed paradox or were predictors of prognosis.Methods: A retrospective review of data collected from 2006 to 2018 of patients diagnosed with rectal cancer in three separate centres was conducted. Percentages pertaining to patient and tumour characteristics, presentation, management and subsequent recurrence were reported. Preoperative and postoperative factors associated with survival were determined using univariable and multivariable logistic regression analysis.Results: Stage IIB/C patients had significantly higher carcinoembryonic antigen (CEA) levels compared to stage IIA and stage IIIA patients (P < 0.001). Stage IIB/C patients had significantly larger primary rectal tumour and were more symptomatic (i.e. rectal bleeding, altered bowel habits and obstruction) at the time of diagnosis (P = 0.007). Preoperative CEA was an independent prognostic factor for cancer‐specific survival in patients diagnosed with stage IIB/C and stage IIIA disease (P = 0.008) on multivariable analysis. Overall survival was greatest in stage IIIA disease, which was significantly greater than stage IIB/C disease.Conclusion: This study confirms the existence of a survival paradox in patients diagnosed with CRC in an Australian tertiary centre and adds further weight to the revision of the TNM staging to provide more emphasis on the T stage.
- 6 April 2021
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (9) , 1866-1873
Survival in stage IIB/C compared to stage IIIA rectal cancer: an Australian experience affirming that size does matter
Background: Colorectal cancer (CRC) is one of the most commonly diagnosed malignancies globally; however, a survival paradox has been observed unique to this malignancy. The aim of this study was to review survival outcomes of patients diagnosed with stage II and stage III rectal cancer, to determine whether a survival paradox is present in our centre and assess for patient‐related factors that can explain the observed paradox or were predictors of prognosis.Methods: A retrospective review of data collected from 2006 to 2018 of patients diagnosed with rectal cancer in three separate centres was conducted. Percentages pertaining to patient and tumour characteristics, presentation, management and subsequent recurrence were reported. Preoperative and postoperative factors associated with survival were determined using univariable and multivariable logistic regression analysis.Results: Stage IIB/C patients had significantly higher carcinoembryonic antigen (CEA) levels compared to stage IIA and stage IIIA patients (P < 0.001). Stage IIB/C patients had significantly larger primary rectal tumour and were more symptomatic (i.e. rectal bleeding, altered bowel habits and obstruction) at the time of diagnosis (P = 0.007). Preoperative CEA was an independent prognostic factor for cancer‐specific survival in patients diagnosed with stage IIB/C and stage IIIA disease (P = 0.008) on multivariable analysis. Overall survival was greatest in stage IIIA disease, which was significantly greater than stage IIB/C disease.Conclusion: This study confirms the existence of a survival paradox in patients diagnosed with CRC in an Australian tertiary centre and adds further weight to the revision of the TNM staging to provide more emphasis on the T stage.
- Open Access
- 30 March 2021
- Published by MDPI AG in Current Oncology
- Vol. 28 (2) , 1388-1401
Current Treatment Approaches and Outcomes in the Management of Rectal Cancer Above the Age of 80
Background: The number of cases of rectal cancer in our older cohort is expected to rise with our ageing population. In this study, we analysed patterns in treatment and the long-term outcomes of patients older than 80 years with rectal cancer across a health district. Methods: All cases of rectal cancer managed at the Illawarra Cancer Care Centre, Australia between 2006 and 2018 were analysed from a prospectively maintained database. Patients were stratified into three age groups: ≤65 years, 66–79 years and ≥80 years of age. The clinicopathological characteristics, operative and non-operative treatment approach and survival outcomes of the three groups were compared. Results: Six hundred and ninety-nine patients with rectal cancer were managed, of which 118 (17%) were aged 80 and above. Patients above 80 were less likely to undergo surgery (71% vs. 90%, p < 0.001) or receive adjuvant/neoadjuvant chemoradiotherapy (p < 0.05). Of those that underwent surgical resection, their tumours were on average larger (36.5 vs. 31.5 mm, p = 0.019) and 18 mm closer the anal verge (p = 0.001). On Kaplan–Meier analysis, those above 80 had poorer cancer-specific survival when compared to their younger counterparts (p = 0.032), but this difference was no longer apparent after the first year (p = 0.381). Conclusion: Patients above the age of 80 with rectal cancer exhibit poorer cancer-specific survival, which is accounted for in the first year after diagnosis. Priority should be made to optimise care during this period. There is a need for further research to establish the role of chemoradiotherapy in this population, which appears to be underutilised.
- 30 March 2021
- Published by MDPI AG in Current Oncology
- Vol. 28 (2) , 1388-1401
Open AccessCurrent Treatment Approaches and Outcomes in the Management of Rectal Cancer Above the Age of 80
Background: The number of cases of rectal cancer in our older cohort is expected to rise with our ageing population. In this study, we analysed patterns in treatment and the long-term outcomes of patients older than 80 years with rectal cancer across a health district. Methods: All cases of rectal cancer managed at the Illawarra Cancer Care Centre, Australia between 2006 and 2018 were analysed from a prospectively maintained database. Patients were stratified into three age groups: ≤65 years, 66–79 years and ≥80 years of age. The clinicopathological characteristics, operative and non-operative treatment approach and survival outcomes of the three groups were compared. Results: Six hundred and ninety-nine patients with rectal cancer were managed, of which 118 (17%) were aged 80 and above. Patients above 80 were less likely to undergo surgery (71% vs. 90%, p < 0.001) or receive adjuvant/neoadjuvant chemoradiotherapy (p < 0.05). Of those that underwent surgical resection, their tumours were on average larger (36.5 vs. 31.5 mm, p = 0.019) and 18 mm closer the anal verge (p = 0.001). On Kaplan–Meier analysis, those above 80 had poorer cancer-specific survival when compared to their younger counterparts (p = 0.032), but this difference was no longer apparent after the first year (p = 0.381). Conclusion: Patients above the age of 80 with rectal cancer exhibit poorer cancer-specific survival, which is accounted for in the first year after diagnosis. Priority should be made to optimise care during this period. There is a need for further research to establish the role of chemoradiotherapy in this population, which appears to be underutilised.
- 16 March 2021
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (9) , 1854-1858
Surgical technique is the main predictor of recurrence in the management of haemorrhoids
Background The pursuit of better management for haemorrhoidal disease (HD) is far from over, and even with the latest surgical procedures, none of the treatment options is close to perfect. The aims of this study were to review our experience with patients treated for symptomatic HD, compare the different treatment strategies in terms of complication and recurrence rates and determine predictors of recurrence. Methods A total of 1958 patients who underwent a procedure for HD performed by a single colorectal consultant surgeon between 2000 and 2015 were reviewed. Results The treatment performed was rubber band ligation (RBL) in 73%, excisional haemorrhoidectomy (EH) in 16% and stapled haemorrhoidopexy (SH) in 11%. After a mean follow‐up of 42.1 months, 242 patients (12%) developed recurrence. Logistic regression analysis of multiple factors showed that treatment received was a significant predictor of recurrence. RBL had the lowest post‐operative complication rate but had the highest recurrence rate. EH had the lowest recurrence rate. SH had the highest complication rate but with similar recurrence rates to EH. Complications included pain, anal fissure, bleeding and urinary retention. Conclusion Low‐grade HD can initially be treated with RBL with good results. Although conventional EH remains a mainstay operation for recurrent and complicated HD, SH can also be considered in selected cases particularly when performed by a surgeon with adequate experience. Treatment should be tailored to the individual based on patient preference, suitability, degree of haemorrhoids and symptomatology.
- 16 March 2021
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (9) , 1854-1858
Surgical technique is the main predictor of recurrence in the management of haemorrhoids
Background The pursuit of better management for haemorrhoidal disease (HD) is far from over, and even with the latest surgical procedures, none of the treatment options is close to perfect. The aims of this study were to review our experience with patients treated for symptomatic HD, compare the different treatment strategies in terms of complication and recurrence rates and determine predictors of recurrence. Methods A total of 1958 patients who underwent a procedure for HD performed by a single colorectal consultant surgeon between 2000 and 2015 were reviewed. Results The treatment performed was rubber band ligation (RBL) in 73%, excisional haemorrhoidectomy (EH) in 16% and stapled haemorrhoidopexy (SH) in 11%. After a mean follow‐up of 42.1 months, 242 patients (12%) developed recurrence. Logistic regression analysis of multiple factors showed that treatment received was a significant predictor of recurrence. RBL had the lowest post‐operative complication rate but had the highest recurrence rate. EH had the lowest recurrence rate. SH had the highest complication rate but with similar recurrence rates to EH. Complications included pain, anal fissure, bleeding and urinary retention. Conclusion Low‐grade HD can initially be treated with RBL with good results. Although conventional EH remains a mainstay operation for recurrent and complicated HD, SH can also be considered in selected cases particularly when performed by a surgeon with adequate experience. Treatment should be tailored to the individual based on patient preference, suitability, degree of haemorrhoids and symptomatology.